Malaria species positivity rates among symptomatic individuals across regions of differing transmission intensities in Mainland Tanzania.

Plasmodium falciparum Plasmodium malariae Plasmodium ovale Plasmodium vivax Tanzania malaria non-falciparum species

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
22 Nov 2023
Historique:
received: 20 09 2023
revised: 09 11 2023
accepted: 20 11 2023
medline: 22 11 2023
pubmed: 22 11 2023
entrez: 22 11 2023
Statut: aheadofprint

Résumé

Recent data indicate that non-Plasmodium falciparum species may be more prevalent than thought in sub-Saharan Africa. Although Plasmodium malariae, Plasmodium ovale spp., and Plasmodium vivax are less severe than P. falciparum, treatment and control are more challenging, and their geographic distributions are not well characterized. We randomly selected 3,284 of 12,845 samples collected from cross-sectional surveys in 100 health facilities across ten regions of Mainland Tanzania and performed quantitative real-time PCR to determine presence and parasitemia of each malaria species. P. falciparum was most prevalent, but P. malariae and P. ovale were found in all but one region, with high levels (>5%) of P. ovale in seven regions. The highest P. malariae positivity rate was 4.5% in Mara and eight regions had positivity rates ≥1%. We only detected three P. vivax infections, all in Kilimanjaro. While most non-falciparum malaria-positive samples were co-infected with P. falciparum, 23.6% (n = 13/55) of P. malariae and 14.7% (n = 24/163) of P. ovale spp. were mono-infections. P. falciparum remains by far the largest threat, but our data indicate that malaria elimination efforts in Tanzania will require increased surveillance and improved understanding of the biology of non-falciparum species.

Sections du résumé

BACKGROUND BACKGROUND
Recent data indicate that non-Plasmodium falciparum species may be more prevalent than thought in sub-Saharan Africa. Although Plasmodium malariae, Plasmodium ovale spp., and Plasmodium vivax are less severe than P. falciparum, treatment and control are more challenging, and their geographic distributions are not well characterized.
METHODS METHODS
We randomly selected 3,284 of 12,845 samples collected from cross-sectional surveys in 100 health facilities across ten regions of Mainland Tanzania and performed quantitative real-time PCR to determine presence and parasitemia of each malaria species.
RESULTS RESULTS
P. falciparum was most prevalent, but P. malariae and P. ovale were found in all but one region, with high levels (>5%) of P. ovale in seven regions. The highest P. malariae positivity rate was 4.5% in Mara and eight regions had positivity rates ≥1%. We only detected three P. vivax infections, all in Kilimanjaro. While most non-falciparum malaria-positive samples were co-infected with P. falciparum, 23.6% (n = 13/55) of P. malariae and 14.7% (n = 24/163) of P. ovale spp. were mono-infections.
CONCLUSIONS CONCLUSIONS
P. falciparum remains by far the largest threat, but our data indicate that malaria elimination efforts in Tanzania will require increased surveillance and improved understanding of the biology of non-falciparum species.

Identifiants

pubmed: 37992117
pii: 7441649
doi: 10.1093/infdis/jiad522
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Auteurs

Zachary R Popkin Hall (ZR)

Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA 27599.

Misago D Seth (MD)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Rashid A Madebe (RA)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Rule Budodo (R)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Catherine Bakari (C)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Filbert Francis (F)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Dativa Pereus (D)

National Institute for Medical Research, Dar es Salaam, Tanzania.

David J Giesbrecht (DJ)

The Connecticut Agricultural Experiment Station, New Haven, CT, USA 06511.

Celine I Mandara (CI)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Daniel Mbwambo (D)

National Malaria Control Programme, Dodoma, Tanzania.

Sijenunu Aaron (S)

National Malaria Control Programme, Dodoma, Tanzania.

Abdallah Lusasi (A)

National Malaria Control Programme, Dodoma, Tanzania.

Samwel Lazaro (S)

National Malaria Control Programme, Dodoma, Tanzania.

Jeffrey A Bailey (JA)

Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, RI, USA 02906.
Center for Computational Molecular Biology, Brown University, RI, USA 02906.

Jonathan J Juliano (JJ)

Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA 27599.

Deus S Ishengoma (DS)

National Institute for Medical Research, Dar es Salaam, Tanzania.
Harvard T. H. Chan School of Public Health, Boston, MA 02115.
Faculty of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.

Classifications MeSH